CLOOPEN GROUP HOLDING LTD (RAAS)       0.9806  +0 (+0.05%)

0.9806  +0 (+0.05%)

US18900M1045 - ADR - After market: 0.9995 +0.02 (+1.93%)


Fundamental Rating

We assign a fundamental rating of 4 out of 10 to RAAS. RAAS was compared to 367 industry peers in the Software industry. The financial health of RAAS is medium. Also its profitability is quite bad. RAAS shows excellent growth, but is valued quite expensive already.




Profitability

Profitability Rating


The Piotroski-F score of RAAS is 5.00. This is a neutral score and indicates average health and profitability for RAAS.
RAAS has negative profitability rations, so we won't be analyzing them here.

RAAS's Return On Assets of -19.58% is worse than the rest of the industry. The industry average Return On Assets is -6.96%.
RAAS's Profit Margin of -67.63% is worse than the rest of the industry. The industry average Profit Margin is -16.49%.
VS Industry

ROA (-19.58%) VS Industry: 30% outperformed.

-2,059.71
121.06

Profit Margin (-67.63%) VS Industry: 21% outperformed.

-250,914.83
483.62

Valuation

Valuation Rating


With a price book ratio of 0.36, RAAS is valued rather cheaply.
Compared to an average industry price book ratio of 3.44, RAAS is valued rather cheaply. On top of this, RAAS is cheaper than 97% of the companies listed in the same industry.
When comparing the Enterprise Value to EBITDA ratio of RAAS to the average industry ratio of 22.46, RAAS is valued rather cheaply. RAAS is also cheaper than 89% of the companies listed in the same industry.

RAAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RAAS. No positive earnings are expected for the next year.
VS Industry

Price/Book (0.36) VS Industry: 97% outperformed.

1,001.11
0.10

Enterprise Value/ EBITDA (3.56) VS Industry: 89% outperformed.

3,479.39
0.08

Growth

Growth Rating


Looking at the last year, RAAS shows a quite strong growth in Revenue. The Revenue has grown by 18.05% in the last year.
The Revenue has been growing by 23.73% on average over the past 5 years. This is a very strong growth!
The Revenue is expected to grow by 33.06% on average over the next 5 years. This is a very strong growth

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Based on estimates for the next 5 years, RAAS will show a small growth in Earnings Per Share. The EPS will grow by 1.29% on average per year.
The earnings per share for RAAS have decreased strongly by -181.58% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -181.58% -63.66% -0.04% 16.05% 1.29%
RevenueN/A 23.73% 18.05% 31.01% 33.04% 33.15% 33.06%

Health

Health Rating


A Current Ratio of 7.22 indicates that RAAS has no problem at all paying its short term obligations.
The Current Ratio of RAAS is much better than the industry average of 1.86. RAAS has a better rating than 87% of its industry peers.
A Quick Ratio of 7.22 indicates that RAAS has no problem at all paying its short term obligations.
RAAS is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.85. RAAS has a better rating than 87% of its industry peers.

The Debt to Equity ratio of RAAS is in line with the industry averages.
RAAS has a Piotroski-F score of 5.00. This indicates an average health and profitability for RAAS.
RAAS has an Altman-Z score of -1.23. This is a bad value and indicates that RAAS is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.42, RAAS is in worse financial state than most of its industry peers. 85% of its industry peers have a better Altman-Z score.
VS Industry

Debt/Equity (0) VS Industry: 57% outperformed.

86.92
-29.11

Quick Ratio (7.22) VS Industry: 87% outperformed.

0.05
211.52

Current Ratio (7.22) VS Industry: 87% outperformed.

0.05
211.52

Altman-Z (-1.23) VS Industry: 15% outperformed.

-190.75
193.89

Dividend

Dividend Rating


No dividends for RAAS!.

RAAS Daily chart

CLOOPEN GROUP HOLDING LTD0.9806

NYSE:RAAS (8/10/2022, 7:08:51 PM)+0 (+0.05%)

After market: 0.9995 +0.02 (+1.93%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Software & Services
GICS Industry Software
Earnings (Last) 08-09 2022-08-09 Earnings (Next) 11-16 2022-11-16
Ins Owners N/A Inst Owners 6.08%
Market Cap 161.18M Analysts 85
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S 1.07 P/B 0.36
EV/EBITDA 3.56
Profitability
ROA -19.58% ROE N/A
PM -67.63 Asset Turnover 0.29
Growth
EPS 1Y -181.58% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -19.63%
EPS Next Y -63.66% EPS Next 2Y -0.04%
EPS Next 3Y 16.05% EPS Next 5Y 1.29%
Revenue growth 1Y 18.05% Revenue growth 3Y 23.73%
Revenue growth 5Y N/A Revenue growth Q2Q 44.34%
Revenue Next Year 31.01% Revenue Next 2Y 33.04%
Revenue Next 3Y 33.15% Revenue Next 5Y 33.06%
Health
Current Ratio 7.22 Quick Ratio 7.22
Altman-Z -1.23 F-Score 5
Debt/Equity N/A
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA